Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Treatment of vulvovaginal candidiasis: a review of the literature.
Dovnik A, Golle A, Novak D, Arko D, Takač I.
Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(1):5-7. doi: 10.15570/actaapa.2015.2.
PMID:25770305
Biofilms and vulvovaginal candidiasis.
Rodríguez-Cerdeira C, Gregorio MC, Molares-Vila A, López-Barcenas A, Fabbrocini G, Bardhi B, Sinani A, Sánchez-Blanco E, Arenas-Guzmán R, Hernandez-Castro R.
Colloids Surf B Biointerfaces. 2019 Feb 1;174:110-125. doi: 10.1016/j.colsurfb.2018.11.011. Epub 2018 Nov 7.
PMID:30447520
Recurrent vulvovaginal candidiasis.
Belayneh M, Sehn E, Korownyk C.
Can Fam Physician. 2017 Jun;63(6):455.
PMID:28615397
The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis.
Zahedifard T, Khadivzadeh T, Rakhshkhorshid M.
Ethiop J Health Sci. 2023 Sep;33(5):881-890. doi: 10.4314/ejhs.v33i5.18.
PMID:38784519
Recurrent vulvovaginal candidiasis.
Blostein F, Levin-Sparenberg E, Wagner J, Foxman B.
Ann Epidemiol. 2017 Sep;27(9):575-582.e3. doi: 10.1016/j.annepidem.2017.08.010. Epub 2017 Aug 15.
PMID:28927765
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.